Literature DB >> 28129550

ATP binding cassette A1 (ABCA1) mediates microparticle formation during high-density lipoprotein (HDL) biogenesis.

Anouar Hafiane1, Jacques Genest2.   

Abstract

BACKGROUND AND AIMS: Micro-particles (MP) are secreted by various cells. Their biological roles in health and in disease remain unknown. Here we describe formation of MP in the process of ABCA1-dependent cholesterol efflux in different cell types.
METHODS: The ATP-binding cassette transporter, subfamily A, member 1 (ABCA1) is the rate-limiting step in the biogenesis of high-density lipoproteins (HDL). We have found that ABCA1 and apoA-I contribute to the formation of MP. Using cell-based systems with overexpression and selective inactivation of ABCA1, pharmacological blockade and modulation of membrane cholesterol content, we characterized MP release from various cell lines. We studied MP release in BHK cells stably expressing ABCA1 under mifepristone control, human THP-1 macrophages and HepG2 cells without, or with incubation with human apoA-I.
RESULTS: ABCA1 mediates the production of MPs containing cholesterol. This was also confirmed in primary human monocyte-derived macrophages (MDMs). Adding apoA-I markedly increases MP release from cells. Inhibition of ABCA1 with probucol or decreasing plasma membrane cholesterol with methyl-β cyclodextrin (CDX) markedly reduced MP release and nascent HDL formation. MPs do not contain apoA-I, but contain flotilin-2, a marker of plasma membrane, and CD63, an exosome marker. MPs exhibit considerable size heterogeneity (50-250 nm).
CONCLUSIONS: We show that MPs are lipoprotein-sized structures created by the ABCA1 transporter, and contribute approximately 30% of ABCA1-and apoA-I mediated cholesterol efflux. In addition, we found that MPs release from cells consists, in part, of exosomes and depends on the same pathway used for HDL biogenesis.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ABCA1; Apolipoprotein apoA-I; CD63; Cholesterol efflux; Flotillin-2; HDL; Microparticles

Mesh:

Substances:

Year:  2017        PMID: 28129550     DOI: 10.1016/j.atherosclerosis.2017.01.013

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  23 in total

Review 1.  Is ABCA1 a lipid transfer protein?

Authors:  Michael C Phillips
Journal:  J Lipid Res       Date:  2018-01-05       Impact factor: 5.922

2.  Macrophages release plasma membrane-derived particles rich in accessible cholesterol.

Authors:  Cuiwen He; Xuchen Hu; Thomas A Weston; Rachel S Jung; Jaspreet Sandhu; Song Huang; Patrick Heizer; Jason Kim; Rochelle Ellison; Jiake Xu; Matthew Kilburn; Steven J Bensinger; Howard Riezman; Peter Tontonoz; Loren G Fong; Haibo Jiang; Stephen G Young
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-20       Impact factor: 11.205

Review 3.  HDL and Reverse Cholesterol Transport.

Authors:  Mireille Ouimet; Tessa J Barrett; Edward A Fisher
Journal:  Circ Res       Date:  2019-05-10       Impact factor: 17.367

Review 4.  Cholesterol and the journey of extracellular vesicles.

Authors:  Frank W Pfrieger; Nicolas Vitale
Journal:  J Lipid Res       Date:  2018-04-20       Impact factor: 5.922

Review 5.  Research progress of signaling pathways of the natural substances intervene dyslipidemia (Review).

Authors:  Ningning Cao; Xiaoxuan Li; Wanjing Zhang; Qingguo Wang; Yujuan Liang; Fujun Zhou; Xuefeng Xiao
Journal:  Exp Ther Med       Date:  2022-06-07       Impact factor: 2.751

Review 6.  Novel Approaches for HDL-Directed Therapies.

Authors:  Jacques Genest; Hong Y Choi
Journal:  Curr Atheroscler Rep       Date:  2017-11-04       Impact factor: 5.113

7.  N-terminal mutation of apoA-I and interaction with ABCA1 reveal mechanisms of nascent HDL biogenesis.

Authors:  Minjing Liu; Xiaohu Mei; Haya Herscovitz; David Atkinson
Journal:  J Lipid Res       Date:  2018-09-24       Impact factor: 5.922

8.  Identification of Differentially Expressed Genes and Elucidation of Pathophysiological Relevance of ABCA1 in HaCaT Cells Induced by PM2.5.

Authors:  Fen Peng; Chen-Hong Xue; Xiao-Jing Yang; Jing-Yi Huang; Zhou Chen; Jian-Zhong Zhang
Journal:  Bioinorg Chem Appl       Date:  2021-04-20       Impact factor: 7.778

Review 9.  Pharmacological Intervention to Modulate HDL: What Do We Target?

Authors:  Nicholas J Woudberg; Sarah Pedretti; Sandrine Lecour; Rainer Schulz; Nicolas Vuilleumier; Richard W James; Miguel A Frias
Journal:  Front Pharmacol       Date:  2018-01-22       Impact factor: 5.810

10.  Thyroid transcription factor 1 enhances cellular statin sensitivity via perturbing cholesterol metabolism.

Authors:  Shao-Chiang Lai; Cody A Phelps; Aleena M Short; Sucharita M Dutta; David Mu
Journal:  Oncogene       Date:  2018-03-19       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.